The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure.

PubWeight™: 5.29‹?› | Rank: Top 1%

🔗 View Article (PMID 8697828)

Published in Chest on August 01, 1996


L P Cahalin1, M A Mathier, M J Semigran, G W Dec, T G DiSalvo

Author Affiliations

1: Massachusetts General Hospital Physical Therapy Services, Boston 02114, USA.

Articles citing this

Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul study. Arch Intern Med (2012) 3.50

6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure. J Am Coll Cardiol (2012) 3.03

Heart failure: Part I. First hospitalization and post-hospital care. West J Med (1999) 2.10

A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial). Eur Heart J (2015) 2.08

Relationship between ambulatory capacity and cardiorespiratory fitness in chronic stroke: influence of stroke-specific impairments. Chest (2005) 2.02

The SF-36 and 6-Minute Walk Test are Significant Predictors of Complications After Major Surgery. World J Surg (2015) 2.01

The 6-min walk test in heart failure: is it a max or sub-maximum exercise test? Eur J Appl Physiol (2009) 1.95

Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes. Am J Psychiatry (2014) 1.94

Assessment of oxygen uptake during the six-minute walk test in patients with heart failure. Chest (1997) 1.39

Maximal exercise test is a useful method for physical capacity and oxygen consumption determination in streptozotocin-diabetic rats. Cardiovasc Diabetol (2007) 1.34

Small increase of actual physical activity 6 months after total hip or knee arthroplasty. Clin Orthop Relat Res (2008) 1.28

The 6-minute walk is associated with frailty and predicts mortality in older adults with heart failure. Congest Heart Fail (2010) 1.26

Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients. J Am Coll Cardiol (2015) 1.25

Prognostic value of 6-minute walk test in stable outpatients with heart failure. Tex Heart Inst J (2007) 1.23

Examination of the six minute walk test to determine functional capacity in people with chronic heart failure: a systematic review. Cardiopulm Phys Ther J (2010) 1.19

Falls in patients with chronic obstructive pulmonary disease: a call for further research. Respir Med (2009) 1.18

Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation. J Heart Lung Transplant (2009) 1.13

The six minute walk test accurately estimates mean peak oxygen uptake. BMC Pulm Med (2010) 1.13

A randomized study of reinforcing ambulatory exercise in older adults. Psychol Aging (2013) 1.04

Glycated hemoglobin and associated risk factors in older adults. Cardiovasc Diabetol (2012) 1.03

Relation between six-minute walk test performance and outcomes after transcatheter aortic valve implantation (from the PARTNER trial). Am J Cardiol (2013) 0.98

Six-minute walk test for persons with mild or moderate disability from multiple sclerosis: performance and explanatory factors. Physiother Can (2011) 0.96

The effect of erythropoietin on exercise capacity, left ventricular remodeling, pressure-volume relationships, and quality of life in older patients with anemia and heart failure with preserved ejection fraction. Congest Heart Fail (2010) 0.96

Maximum daily 6 minutes of activity: an index of functional capacity derived from actigraphy and its application to older adults with heart failure. J Am Geriatr Soc (2010) 0.96

Functional capacity and actual daily activity do not contribute to patient satisfaction after total knee arthroplasty. BMC Musculoskelet Disord (2010) 0.94

Comparison of health related quality of life with cardiopulmonary exercise testing in adolescents and adults with congenital heart disease. Heart (2005) 0.94

The effect of patient choice of intervention on health outcomes. Contemp Clin Trials (2008) 0.93

Triangulating Clinically Meaningful Change in the Six-minute Walk Test in Individuals with Chronic Heart Failure: A Systematic Review. Cardiopulm Phys Ther J (2012) 0.92

Effects of a renal rehabilitation exercise program in patients with CKD: a randomized, controlled trial. Clin J Am Soc Nephrol (2014) 0.92

Reproducibility of the self-controlled six-minute walking test in heart failure patients. Clinics (Sao Paulo) (2008) 0.92

Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure. Am J Cardiol (2014) 0.91

Association of chronic cough and pulmonary function with 6-minute walk test performance in HIV infection. J Acquir Immune Defic Syndr (2014) 0.90

Clinically meaningful change estimates for the six-minute walk test and daily activity in individuals with chronic heart failure. Cardiopulm Phys Ther J (2013) 0.88

Prognostic value of the six-minute walk test in heart failure patients undergoing cardiac surgery: a literature review. Rehabil Res Pract (2013) 0.88

Prediction of cardiorespiratory fitness in older men infected with the human immunodeficiency virus: clinical factors and value of the six-minute walk distance. J Am Geriatr Soc (2009) 0.87

Assessment of exercise capacity in African patients with chronic heart failure using six minutes walk test. Int J Gen Med (2010) 0.86

Effect of body weight loss on cardiopulmonary function assessed by 6-minute walk test and arterial blood gas analysis in obese dogs. J Vet Intern Med (2013) 0.86

Factors related to time to admission to specialized multidisciplinary clinics in patients with congestive heart failure. Can J Cardiol (2009) 0.86

Comparison of walking performance over the first 2 minutes and the full 6 minutes of the Six-Minute Walk Test. BMC Res Notes (2014) 0.84

Association of the veterans aging cohort study index with exercise capacity in HIV-infected adults. AIDS Res Hum Retroviruses (2013) 0.84

Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study. Circ Heart Fail (2013) 0.83

Oxygen uptake kinetics during low level exercise in patients with heart failure: relation to neurohormones, peak oxygen consumption, and clinical findings. Heart (1999) 0.83

Factors associated with the 6-minute walk test in nursing home residents and community-dwelling older adults. J Phys Ther Sci (2015) 0.82

Utility of the late life function and disability instrument as an outcome measure in patients participating in outpatient cardiac rehabilitation: a preliminary study. Physiother Can (2012) 0.82

Longitudinal change in chronic fatigue syndrome: what home-based assessments reveal. J Behav Med (2008) 0.82

Effects of respiratory muscle and endurance training using an individualized training device on the pulmonary function and exercise capacity in stroke patients. Med Sci Monit (2014) 0.82

The influence of systematic pulse-limited physical exercise on the parameters of the cardiovascular system in patients over 65 years of age. Arch Med Sci (2013) 0.82

Relative and absolute reliability of physical function measures in people with end-stage renal disease. Physiother Can (2010) 0.81

Predicting prognosis in advanced heart failure. Use of exercise indices. Chest (1996) 0.81

Theoretical rationale and practical recommendations for cardiopulmonary exercise testing in patients with chronic heart failure. Heart Fail Rev (2007) 0.81

Association Between 6-Minute Walk Test and All-Cause Mortality, Coronary Heart Disease-Specific Mortality, and Incident Coronary Heart Disease. J Aging Health (2014) 0.80

The role of exercise testing in the evaluation and management of heart failure. Postgrad Med J (1999) 0.80

Rationale, design and baseline data for the Activating Consumers to Exercise through Peer Support (ACE trial): A randomized controlled trial to increase fitness among adults with mental illness. Ment Health Phys Act (2012) 0.79

Can exercise capacity assessed by the 6 minute walk test predict the development of major adverse cardiac events in patients with STEMI after fibrinolysis? PLoS One (2014) 0.79

Heart disease management by women: does intervention format matter? Health Educ Behav (2007) 0.78

Case report: exercise in a patient with acute decompensated heart failure receiving positive inotropic therapy. Cardiopulm Phys Ther J (2011) 0.78

Cross-validation of the recumbent stepper submaximal exercise test to predict peak oxygen uptake in older adults. Phys Ther (2014) 0.78

Peak exercise capacity prediction from a submaximal exercise test in coronary artery disease patients. Front Physiol (2013) 0.78

Responsiveness and validity of the six-minute walk test in individuals with traumatic brain injury. Phys Ther (2012) 0.78

Diastolic function is associated with quality of life and exercise capacity in stable heart failure patients with reduced ejection fraction. Braz J Med Biol Res (2013) 0.78

The effect of chest expansion resistance exercise in chronic stroke patients: a randomized controlled trial. J Phys Ther Sci (2015) 0.78

The results of cardiopulmonary exercise test in healthy Korean children and adolescents: single center study. Korean J Pediatr (2013) 0.78

Autonomic dysfunction predicts poor physical improvement after cardiac rehabilitation in patients with heart failure. Res Cardiovasc Med (2014) 0.77

Distance saturation product predicts health-related quality of life among sarcoidosis patients. Health Qual Life Outcomes (2012) 0.77

Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial. PLoS One (2014) 0.77

Cardiovascular medicine heart failure (CVM-HF) index as prognostic model for candidates to MitraClip therapy. Heart Vessels (2015) 0.77

Could peak oxygen uptake be estimated from proposed equations based on the six-minute walk test in chronic heart failure subjects? Braz J Phys Ther (2017) 0.76

Evaluation of an exercise field test using heart rate monitors to assess cardiorespiratory fitness and heart rate recovery in an asymptomatic population. PLoS One (2014) 0.76

Consensus on measurement properties and feasibility of performance tests for the exercise and sport sciences: a Delphi study. Sports Med Open (2017) 0.75

Detection of calf muscle alterations in patients with chronic heart failure by P magnetic resonance spectroscopy: Impaired adaptation to continuous exercise. Exp Clin Cardiol (2005) 0.75

Impaired skeletal muscle vasodilation during exercise in heart failure with preserved ejection fraction. Int J Cardiol (2016) 0.75

A Cardiopulmonary Instructor's Perspective on a Standardized Patient Experience: Implications for Cardiopulmonary Physical Therapy Education. Cardiopulm Phys Ther J (2011) 0.75

Clinical Classification of Heart Failure Patients Using Cardiac Function during Exercise. Exerc Sport Sci Rev (2015) 0.75

The contribution of exercise testing in the prescription and outcome evaluation of exercise training in pulmonary rehabilitation. Maedica (Buchar) (2012) 0.75

Quantifying and Reducing Motion Artifacts in Wearable Seismocardiogram Measurements during Walking to Assess Left Ventricular Health. IEEE Trans Biomed Eng (2016) 0.75

Study of adherence to exercise in heart failure: the HEART camp trial protocol. BMC Cardiovasc Disord (2014) 0.75

Passive smoking and the 6-minute walk test in heart failure. Chest (1997) 0.75

Six-Minute Walk Test as a Predictor for Outcome in Children with Dilated Cardiomyopathy and Chronic Stable Heart Failure. Pediatr Cardiol (2016) 0.75

End points in heart failure-are we doing it right? Eur J Clin Pharmacol (2017) 0.75

Novel Endpoints for Heart Failure Clinical Trials. Curr Heart Fail Rep (2017) 0.75

Safety of early performance of the six-minute walk test following acute myocardial infarction: a cross-sectional study. Braz J Phys Ther (2017) 0.75

Articles by these authors

Apoptosis in myocytes in end-stage heart failure. N Engl J Med (1996) 6.19

Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation (1999) 3.19

Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation (1995) 2.97

Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol (1995) 2.84

Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A (1999) 2.42

Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. Circulation (1990) 2.22

Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci U S A (1998) 2.19

Brief report: recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med (1993) 2.14

Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med (1985) 1.99

Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data. J Am Coll Cardiol (1999) 1.89

Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes. Circulation (1991) 1.85

Socioeconomic status as an independent risk factor for hospital readmission for heart failure. Am J Cardiol (2001) 1.81

beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation. Circ Res (1997) 1.73

Quality of care and hospital readmission in congestive heart failure: an explicit review process. J Card Fail (2001) 1.63

Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis. J Nucl Cardiol (1997) 1.58

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation (2001) 1.56

Effect of vesnarinone on cardiac function in patients with severe congestive heart failure. Am Heart J (1998) 1.52

Inhaled nitric oxide improves exercise capacity in patients with severe heart failure and right ventricular dysfunction. Am J Cardiol (1998) 1.47

Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant (1998) 1.46

Inotropic effect of nicardipine in patients with heart failure: assessment by left ventricular end-systolic pressure-volume analysis. J Am Coll Cardiol (1989) 1.44

Inspiratory muscle training in patients with chronic heart failure awaiting cardiac transplantation: results of a pilot clinical trial. Phys Ther (1997) 1.43

Potential impact of pulmonary artery catheter placement on short-term management decisions in the medical intensive care unit. Am Heart J (1993) 1.40

Relationship between pulmonary artery diameter at computed tomography and pulmonary artery pressures at right-sided heart catheterization. Massachusetts General Hospital Lung Transplantation Program. Acad Radiol (1997) 1.39

Effects of disopyramide on left ventricular diastolic function in hypertrophic cardiomyopathy. Am J Cardiol (1994) 1.38

Socioeconomic status is an important determinant of the use of invasive procedures after acute myocardial infarction in New York State. Circulation (2000) 1.34

Klippel-Trénaunay syndrome with multiple pulmonary emboli--an unusual cause of progressive pulmonary dysfunction. J Vasc Surg (1995) 1.25

Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. Circulation (1999) 1.23

Ten-year trends in hospital care for congestive heart failure: improved outcomes and increased use of resources. Arch Intern Med (2000) 1.20

Influence of race and gender on care process, resource use, and hospital-based outcomes in congestive heart failure. Am J Cardiol (1998) 1.20

Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J (1994) 1.15

Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol (1994) 1.08

Apoptosis in the failing heart. Cardiol Clin (1998) 1.03

Cardiovascular complications following liver transplantation. Clin Transplant (1995) 1.01

Combined immunosuppression for the treatment of idiopathic giant cell myocarditis. Mayo Clin Proc (1999) 1.01

The spectrum of pulmonary abnormalities on computed chest tomographic imaging in patients with advanced heart failure. Am J Cardiol (2000) 1.01

Outcome following isolated tricuspid valve replacement. Eur J Cardiothorac Surg (2001) 1.00

Usefulness of echocardiographic determined tricuspid regurgitation in predicting event-free survival in severe heart failure secondary to idiopathic-dilated cardiomyopathy or to ischemic cardiomyopathy. Am J Cardiol (1998) 1.00

Dilated cardiomyopathy associated with simian AIDS in nonhuman primates. Circulation (2000) 0.99

Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension. Chest (2001) 0.98

Geriatric patients with acute myocardial infarction: Cardiac risk factor profiles, presentation, thrombolysis, coronary interventions, and prognosis. Am Heart J (1996) 0.94

Oxygen therapy improves cardiac index and pulmonary vascular resistance in patients with pulmonary hypertension. Chest (2001) 0.93

Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group. J Am Coll Cardiol (2000) 0.93

Inhaled nitric oxide increases coronary artery patency after thrombolysis. Circulation (1996) 0.93

Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy. J Am Coll Cardiol (1998) 0.92

Myocardial stunning in hyperthyroidism. Clin Cardiol (2000) 0.89

Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry. Transplantation (1997) 0.89

Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts. Gene Ther (2007) 0.88

Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure. J Heart Lung Transplant (2000) 0.88

Managed care for congestive heart failure: influence of payer status on process of care, resource utilization, and short-term outcomes. Am Heart J (1998) 0.88

Restrictive cardiomyopathy versus constrictive pericarditis: role of endomyocardial biopsy in avoiding unnecessary thoracotomy. Circulation (1987) 0.88

Biopsy-induced flail tricuspid leaflet and tricuspid regurgitation following orthotopic cardiac transplantation. Am J Cardiol (1996) 0.88

Underuse of invasive procedures among Medicaid patients with acute myocardial infarction. Am J Public Health (2001) 0.88

Length of stay and procedure utilization are the major determinants of hospital charges for heart failure. Clin Cardiol (2001) 0.87

Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol. Am J Physiol (1999) 0.87

Linearity of the left ventricular end-systolic pressure-volume relation in patients with severe heart failure. J Am Coll Cardiol (1989) 0.86

The prevention and management of iodine-induced hyperthyroidism and its cardiac features. Thyroid (1998) 0.85

Indium 111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis. Circulation (1987) 0.85

Do gender-based differences in presentation and management influence predictors of hospitalization costs and length of stay after an acute myocardial infarction? Am J Cardiol (1995) 0.84

Palpitations and cardiac awareness after heart transplantation. Psychosom Med (1998) 0.84

Results of heart transplantation for active lymphocytic myocarditis. J Heart Transplant (1990) 0.81

Evaluation of ischemic heart disease in potential lung transplant recipients. J Heart Lung Transplant (1995) 0.81

Effects of atrial natriuretic factor on coronary hemodynamics and myocardial energetics in patients with heart failure. Am Heart J (1988) 0.80

Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis (2007) 0.80

Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression. J Heart Lung Transplant (1996) 0.80

Effects of atrial natriuretic peptide on myocardial contractile and diastolic function in patients with heart failure. J Am Coll Cardiol (1992) 0.79

Role of cardiac nerves in the cardiovascular response to cocaine in conscious dogs. Circulation (2001) 0.79

Apoptosis in heart failure: a tale of heightened expectations, unfulfilled promises and broken hearts em leader. Apoptosis (1998) 0.79

Ventricular remodeling in active myocarditis. Myocarditis Treatment Trial. Am Heart J (1999) 0.79

Positive inotropic and lusitropic effects of intravenous flosequinan in patients with heart failure. J Am Coll Cardiol (1992) 0.79

The effects of electroconvulsive therapy on serial electrocardiograms and serum cardiac enzyme values. A prospective study of depressed hospitalized inpatients. JAMA (1985) 0.78

Intraventricular conduction abnormalities in patients with clinically suspected myocarditis are associated with myocardial necrosis. Am Heart J (1994) 0.78

Pattern of changes over time in myocardial blood flow and microvascular dilator capacity in patients with normally functioning cardiac allografts. Am J Cardiol (1998) 0.78

Clonal analysis of graft-infiltrating lymphocytes from renal and cardiac biopsies. Dominant rearrangements of TcR beta genes and persistence of dominant rearrangements in serial biopsies. Hum Immunol (1990) 0.78

Cessation of platelet-mediated cyclic canine coronary occlusion after thrombolysis by combining nitric oxide inhalation with phosphodiesterase-5 inhibition. J Am Coll Cardiol (2001) 0.78

Diastolic function in patients with severe heart failure: comparison of the effects of enoximone and nitroprusside. Circulation (1987) 0.78